Trials / Recruiting
RecruitingNCT05871762
Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer
Choice of the Optimal Treatment Strategies for Mid-low REctal Cancer-a National Multi-center, Prospective, Real World Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,705 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy, prognosis, health economics of different treatment modalities of mid-low rectal cancer in different centers in China, and to conduct cost utility analysis (CUA) on the treatment process of rectal cancer to explore the best treatment modality that meets the actual need of medical units in each region and at each level. The investigators hope to provide evidence-based medical suggestions for medical quality control of rectal cancer and revision of clinical guidelines, and provides a source of decision making for medical management and medical insurance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Registry study, no specific intervention | Registry study, no specific intervention |
Timeline
- Start date
- 2023-06-04
- Primary completion
- 2027-05-17
- Completion
- 2027-05-17
- First posted
- 2023-05-23
- Last updated
- 2023-08-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05871762. Inclusion in this directory is not an endorsement.